sums as may be necessary to carry out this subsection. (e) Study on prescription drug monitoring programs (1) In general The Centers for Disease Control and Prevention shall conduct a study on the feasibility of requiring ambulatory and outpatient health care providers to report prescriptions for antimicrobial drugs to a State prescription drug monitoring program, if such a program is available in the practitioners’ States. (2) Report The Centers for Disease Control and Prevention shall submit a report to Congress on the findings of the study under paragraph (1) and make recommendations for the use, improvement, or expansion of State prescription drug monitoring programs to capture information on prescriptions for antimicrobial drugs. . 6. Improving safety in pediatric care (a) Pediatric safety advisory council The Secretary shall establish a Pediatric Safety Advisory Council (referred to in this section as the Council ) to advise and make recommendations on policies to improve pediatric safety and reduce the incidence of health care-acquired conditions in children’s hospitals and other pediatric care settings. (1) Membership The Council shall include at least one of each of the following providers: (A) Neonatologist. (B) Pediatrician. (C) Pediatric infectious disease specialist. (D) Pediatric intensive care specialist. (E) Pediatric hospitalist. (b) Study on the feasibility of children’s hospitals reporting to the nationalhealth care safety network (1) In general The Centers for Disease Control and Prevention shall conduct a study on the appropriateness and feasibility of requiring freestanding children’s hospitals to report information on health care-associated infections to the National Healthcare Safety Network. (2) Content The study under paragraph (1) shall evaluate the applicability of National Health­care Safety Network modules, risk adjustment methodologies, and case definitions to freestanding children’s hospitals. (3) Report The Centers for Disease Control and Prevention shall submit a report to